Deutsche Bank
SPRB

Deutsche Bank’s Spruce Biosciences SPRB Stock Holding History

Deutsche Bank’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-164
Closed -$24K – 4361
2022
Q1 		$24K Buy
164
+94
+134% +$17.5K ﹤0.01% 4031
2021
Q4 		$24K Buy
70
+3
+4% +$893 ﹤0.01% 4109
2021
Q3 		$30K Sell
67
-2
-3% -$1.26K ﹤0.01% 4193
2021
Q2 		$58K Buy
69
+10
+17% +$10.7K ﹤0.01% 4278
2021
Q1 		$74K Sell
59
-6
-9% -$9.21K ﹤0.01% 4123
2020
Q4 		$119K Buy
+65
New +$108K ﹤0.01% 3753

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's SPRB Position: Q2 2022 in Review

Deutsche Bank sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 164 shares — an estimated $24K sold.

Deutsche Bank first reported a position in SPRB in Q4 2020 and held it in 6 quarters. The position peaked at $119K in Q4 2020. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.

  • Deutsche Bank reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 164 Spruce Biosciences shares in Q2 2022, an estimated $24K.
  • Deutsche Bank first reported a position in Spruce Biosciences in Q4 2020 and held it in 6 quarters.
  • Deutsche Bank's Spruce Biosciences position peaked at $119K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.